Refine by
Antibiotic Testing Articles & Analysis
32 news found
A lot of the tests involved rapid tests using kits and wet chemistry. These methods were inaccurate, slow and expensive. ...
The checkerboard test is an experimental method used to evaluate the interaction of two antimicrobial test compounds. In this test, the MIC and MBC values of the test compounds are used individually and combined with the MIC and MBC values of each bacterial strain being evaluated to calculate accumulation. ...
According to the different applications of the test kits, drug discovery test kits can be divided into the following categories: cell apoptosis test kits, cell viability test kits, imaging test kits, mycoplasma test kits, nitric oxide (NO) test kits, reactive oxygen species (ROS) ...
LifeScale’s ability to detect microbial growth earlier than any other commercial technique enables the instrument to be used for both fundamental research, measuring microbial growth and response, or to determine antimicrobial susceptibility in under three hours. A three-hour susceptibility test will allow antibiotic treatment to be tailored to the ...
STEMart, a provider of CRO services dedicated to integrated medical device and diagnostic clinical development, introduced new Antibiotic Potency Tests to assess the bioactivity or potency of various antibiotics for medical devices. The development of these new tests strictly follows the Antibiotics-Microbial ...
BySTEMart
Sterility testing applies to substances, preparations or articles that require sterility. ...
BySTEMart
He will lead the rollout of the LifeScale AST system for rapid antibiotic susceptibility tests, now in U.S. clinical trials for identifying targeted therapy for sepsis. ...
As we rapidly expand our US Early Adopter placements for the Reveal Rapid AST system, Nathan will play a critical role in managing key relationships with lab leaders across the country. The need for Rapid AST testing in the US is clear and early interest has been overwhelming. With the trajectory of antimicrobial resistance and sepsis, labs need access to a fast, scalable Rapid ...
Selux Diagnostics, Inc., which is leading a new era in personalized diagnostics to combat superbug infections and fight antibiotic resistance, today announced it has raised $50 million in Series C financing to support the U.S. commercial launch of its Next-Generation Phenotyping (NGP) rapid Antimicrobial Susceptibility Testing (AST) platform. ...
The biomarker signature has potential to reduce overtreatment of children with antibiotics by more than 3-fold without impacting underuse. These data show that host response tests have an important role to play in treatment guidance in children with acute ...
ByMeMed
Appropriate use of antibiotics can improve patient health, reduce health care costs, and prolong the utility of effective antibiotics. Inappropriate antibiotic use can contribute to the development of antibiotic resistance. ...
ViraBac EZ is intended to help physicians quickly and accurately determine whether to prescribe antibiotics in ambulatory settings. The test will use a capillary blood sample, ideal for use in primary care, urgent care and other outpatient clinical settings. ...
Selux Diagnostics, Inc., which is leading a new era in personalized diagnostics to combat superbug infections and fight antibiotic resistance, today announced that it has received a $2.8 million award from the U.S. ...
Specific Diagnostics today announced results from two studies conducted in the Paris Teaching Hospital System (Assistance Publique-Hôpitaux Paris, AP-HP), Europe’s largest hospital network, reporting performance of the Reveal rapid antibiotic susceptibility testing (AST) system. Both studies, which comprised approximately 225 samples in total, found ...
As a result, middle ear infections are the #1 reason for antibiotic prescriptions and #1 reason for surgery in children. "Our goal is to decrease the usage of antibiotic therapy by 50% for the treatment of middle ear infections," said Caitlin Cameron, CEO OtoNexus Medical Technologies. ...
The new funding will support continued development and commercialization of Inflammatix’s sample-to-answer, point-of-care MyrnaTM test system, which is designed to read RNA using machine learning and produce results in under 30 minutes, as well as continued development of the ViraBac EZTM test (formerly known as HostDx Fever), which reads gene expression ...
K192665, features improvements in susceptibility testing performance for four important antibiotics used to treat Pseudomonas aeruginosa, as well as the addition of the combination of P. aeruginosa and aztreonam, an empiric antibiotic, to the Accelerate PhenoTest BC kit testing panel. ...
The partnership is exclusive to both companies regarding fast AST testing. Thermo Scientific Sensititre Complete Automated AST System is the industry standard for traditional MIC determination. ...
Financing will be used to advance HostDx tests for acute infections and sepsis to commercial launch in 2021. ...
Poster sessions: Rapid Antimicrobial Susceptibility Testing with Broad Antibiotic Menus Using 384-Well: Saturday, Jun. 22, 2019; Presentation Time 1: 11 am-12 pm, Presentation Time 2: 4 pm - 5 pm; CPHM-834; Presenter, Selux Diagnostics, Eric Stern, PhD This poster session describes Selux Diagnostics' next-generation phenotyping (NGP) platform, which employs ...